| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | 0.092 | 0.06 |
| mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | -0.071 | 0.07 |
| mRNA | NSC23766 | CTRPv2 | pan-cancer | AAC | -0.066 | 0.07 |
| mRNA | 16-beta-bromoandrosterone | CTRPv2 | pan-cancer | AAC | -0.071 | 0.07 |
| mRNA | JNK Inhibitor VIII | GDSC1000 | pan-cancer | AAC | 0.067 | 0.07 |
| mRNA | Erlotinib | FIMM | pan-cancer | AAC | 0.34 | 0.07 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.07 |
| mRNA | VER-155008 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.07 |
| mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.07 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | -0.067 | 0.07 |